EO2040
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EO2040, covering 2024-12-19 to 2024-12-19. Get the full timeline:
Most recent: Clinical Trial Update: EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer [Phase 2]